| Vial description: |
Alpha 1B-adrenoceptor, Alpha 1B-adrenoreceptor |
| Category: |
primary antibody |
| Raised in: |
Goat |
| Clone: |
1 vial |
| Form: |
Affinity Purified |
| Reactivity: |
Human |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P35368 |
| Application: |
Western Blot |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
2 or 3 and , Freeze thaw will destroy a percentage in every cycle and should be avoided, However, In this sense, The receptors are ligand binding factors of type 1, This antibody needs to be stored at + 4°, When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, chemokinesor cytokines e, e, sometimes in pharmacology, such as enzymes, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, transporters and ion-channels, - or alpha protein sometimes glycoprotein present in blood, C in a fridge short term in a concentrated dilution, The anti-Alpha-1B adrenergic receptor / ADRA1B (252-264) Antibody is a &alpha, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
Alpha-1B adrenergic receptor / ADRA1B (252-264) |
| Short name: |
anti-Alpha-1B adrenergic receptor / ADRA1B (252-264) Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Alternative name: |
antibody to-a-1B adrenergic receptor / adrenoceptor a 1B (252-264) (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ADRA1 and ALPHA1BAR, ADRA1B and IDBG-55923 and ENSG00000170214 and 147, Adra1b and IDBG-164464 and ENSMUSG00000050541 and 11548, BT, nuclei, protein heterodimerization activity, this GO :0001974 and blood vessel remodeling and biological process this GO :0001975 and response to amphetamine and biological process this GO :0001987 and vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure and biological process this GO :0001996 and positive regulation of heart rate by epinephrine-norepinephrine and biological process this GO :0001997 and positive regulation of the force of heart contraction by epinephrine-norepinephrine and biological process this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004937 and alpha1-adrenergic receptor activity and molecular function this GO :0005634 and nucleus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0007188 and adenylate cyclase-modulating G-protein coupled receptor signaling pathway and biological process this GO :0007267 and cell-cell signaling and biological process this GO :0007275 and multicellular organismal development and biological process this GO :0007512 and adult heart development and biological process this GO :0007626 and locomotory behavior and biological process this GO :0008283 and cell proliferation and biological process this GO :0008542 and visual learning and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0016049 and cell growth and biological process this GO :0019229 and regulation of vasoconstriction and biological process this GO :0031965 and nuclear membrane and cellular component this GO :0035265 and organ growth and biological process this GO :0035556 and intracellular signal transduction and biological process this GO :0042593 and glucose homeostasis and biological process this GO :0043278 and response to morphine and biological process this GO :0043410 and positive regulation of MAPK cascade and biological process this GO :0045818 and negative regulation of glycogen catabolic process and biological process this GO :0045819 and positive regulation of glycogen catabolic process and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0048148 and behavioral response to cocaine and biological process this GO :0055117 and regulation of cardiac muscle contraction and biological process this GO :0071875 and adrenergic receptor signaling pathway and biological process, this GO :0004930 : G-protein coupled receptor activity, this GO :0004930 : G-protein coupled receptor activity and also this GO :0004937 : alpha1-adrenergic receptor activity and also this GO :0046982 : protein heterodimerization activity, this GO :0004937 : alpha1-adrenergic receptor activity, this GO :0046982 : protein heterodimerization activity, 27996 and IDBG-646421 and ENSBTAG00000040253 and 407140, adrenoceptor alpha 1B |
| Identity: |
278 |
| Gene: |
ADRA1B |
More about : ADRA1B |
| Long gene name: |
adrenoceptor alpha 1B |
| Synonyms gene name: |
adrenergic, alpha-1B-, receptor |
| Locus: |
5q33, 3 |
| Discovery year: |
1991-06-04 |
| GenBank acession: |
L31773 |
| Entrez gene record: |
147 |
| Classification: |
Adrenoceptors |
| Havana BLAST/BLAT: |
OTTHUMG00000130327 |